Boston, MA -- (SBWIRE) -- 11/25/2013 -- GlobalData has released its medical devices report, “MediPoint: Drug-Eluting Balloons - US Analysis and Market Forecasts”. The report is an essential source of information and analysis on the drug-eluting balloons (DEB) market in the US. The report provides in-depth insight into the use of DEB for coronary and peripheral applications in the lower extremity including in-stent restenosis, bifurcation lesions, small vessel disease, femoropopliteal artery and below-the-knee lesions, chronic total occlusions, acute myocardial infarction and lesions in diabetics.

View Full Report Details and Table of Contents

The DEB market in the US was assessed to identify the unmet needs in the market, understand the regulatory challenges DEB manufacturers will encounter in the US, identify the challenges to adoption in clinical practice and evaluate future adoption of DEB for select coronary and peripheral indications. The US sales expectations are discussed through careful analysis of adoption patterns of using DEB.

Clients can use this report to better understand the scope of this technology and for strategic planning to explore opportunities in this dynamic market. The report provides insights into the competitive landscape, the marketed and pipeline DEB products, the current and emerging players and comparative market analysis of different types of interventional techniques used to treat coronary and peripheral artery disease. This report is built using data and information sourced from secondary sources and primary research interviews and survey with leading Interventional Cardiologists and Interventional Radiologists, with in-house analysis conducted by GlobalData’s team of industry experts.

Scope

- An overview of coronary artery disease and peripheral artery disease in the lower extremity, which includes epidemiology, pathophysiology, symptoms, diagnosis, and treatment guidelines and modalities.
- Annualized total drug-eluting balloon market revenue by type of disease, annual cost of disease and drug-eluting balloons adoption pattern and procedure data in the US from 2010-2012 and forecast for seven years to 2019.
- Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access and implications of the drug-eluting balloon market.
- Pipeline analysis: comprehensive data split across different stages of development, emerging trends and DEB designs in development, including investigation of DEB coating technology, antiproliferative agent used, balloon and catheter design and durability.
- Analysis of the current and future market competition in the US drug-eluting balloon market. Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to Get This Report

Companies Mentioned in this Report: Aachen Resonance, AnGes MG, AngioScore, AVIDAL Vascular, B. Braun, Biosensors International, Biotronik, Blue Medical, Boston Scientific Corporation, Caliber Therapeutics, Cardionovum, Concept Medical Research, Cook Medical, Covidien, C.R. Bard, DSM Biomedical, Elixir Medical Corporation, Eurocor, LifeTech Scientific Corporation, Medtronic, Micell Technologies, Minvasys, TriReme Medical, Vascular Nanotransfer Technologies

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- MediPoint: Drug-Eluting Balloons - APAC Analysis and Market Forecasts
- MediPoint: Drug-Eluting Balloons - South American Analysis and Market Forecasts
- MediPoint: Drug-Eluting Balloons - EU Analysis and Market Forecasts
- MediPoint: Breast Cancer Imaging - EU Analysis and Market Forecasts
- MediPoint: Breast Cancer Imaging - APAC Analysis and Market Forecasts
- MediPoint: Total Shoulder Replacement - EU Analysis and Market Forecasts
- MediPoint: Predictive Breast Cancer Gene Testing - EU Analysis and Market Forecasts
- MediPoint: Total Shoulder Replacement - APAC Analysis and Market Forecasts
- MediPoint: Breast Cancer Imaging - US Analysis and Market Forecasts
- MediPoint: Breast Cancer Imaging - South America Analysis and Market Forecasts